Wayne Koberstein

  1. Canadian COVID Vax Comes Forward 3/1/2021

    Long before the Warp Speed race, vaccines were a global business more characterized by collaboration than competition. In concert with its national regulator, Health Canada, IMV, Inc. could make world history with its approach to COVID vaccination.

  2. Companies To Watch: PhaseBio 3/1/2021

    PhaseBio is a small, public company aiming to enter a large-market therapeutic area: cardiovascular.

  3. Companies To Watch: Akero Therapeutics 2/1/2021

    Companies To Watch: Akero Therapeutics - Test-proofing a new metabolism drug to beat the liver disease, NASH

  4. RNA's Rousing New Adventure 2/1/2021

    Dicerna shows how the multitude of “co-opportunities” of COVID in the RNA space has further encouraged companies to exploit the unique attributes of those approaches well beyond dealing with the immediate viral threat.

  5. Going Public In Mid-Pandemic 1/4/2021

    Just as the COVID pandemic hit, Timber Pharma was planning on going public. But that wasn’t the only challenge the company faced in the months ahead.

  6. Companies To Watch: Artax Biopharma 1/4/2021

    Artax Biopharma is challenging the immunosuppressive paradigm with a novel drug for autoimmune diseases.

  7. Politics and the Pandemic — Where Are They Taking Biopharma? Industry CEOs Speak Out 12/1/2020

    Seventeen top executives of companies representing the entrepreneurial edge of biopharma innovation provide feedback on how the COVID-19 pandemic and the politics surrounding it could affect their companies’ futures and the industry.

  8. Companies To Watch: Ridgeback Biotherapeutics 10/30/2020

    Ridgeback Biotherapeutics is pitting new and potent antivirals versus COVID, Ebola, and other coronaviruses.

  9. COVID Revs Up The Antibiotics Space 10/1/2020

    NovaBiotics’ CEO, Deborah O’Neil, shares some surprising information about the way Covid has enlivened not only her company’s area of business, but also the antibiotics space industrywide.

  10. Women In Bio: Riding The Waves Of Change 10/1/2020

    WIB’s top execs discuss how the group is faring in the midst of two world-transforming events: the Covid-19 pandemic and the Black Lives Matter protest.